Similar Search Results

Reference pricing as a deterrent to entry : evidence from the European pharmaceutical market

Maini, Luca; Pammolli, Fabio - In: American economic journal 15 (2023) 2, pp. 345-383

Persistent link: https://www.econbiz.de/10014314376

Optimal price regulations in international pharmaceutical markets with generic competition

Geng, Difei; Saggi, Kamal - In: Technology transfer, foreign direct investment, and the …, (pp. 415-433). 2024

Persistent link: https://www.econbiz.de/10014431471

Regulation of brands in the Indian pharmaceutical industry in the 1960s : examination of the Tariff Commission Report : 1968

Kanchan, Manu - In: IIMB Management Review 36 (2024) 1, pp. 83-92

The literature on the Indian pharmaceutical industry has examined the importance of product patents and the attempts policy has made to regulate them. However, it has not done the same for the question of brands. Our study addresses this gap. The Tariff Commission Report of 1968, a turning point...

Persistent link: https://www.econbiz.de/10014636929

Empirical evidence of risk penalties for NTI Drugs

Gentry, Elissa Philip - In: Journal of risk and uncertainty : JRU 58 (2019) 2/3, pp. 219-244

Persistent link: https://www.econbiz.de/10012372762

Essential and orphan drugs in Panama : perception of competition and implications of pricing policy

Herrera Ballesteros, Víctor H.; Moreno Velásquez, Ilais; … - In: Revista de economía del Rosario 23 (2020) 2, pp. 1-20

Persistent link: https://www.econbiz.de/10012426632

The interaction between leading drugs and pharmacy-owned labels in Chile

Escobar E., Gonzalo; Valdés de la Fuente, Iván - In: International journal of business environment : IJBE 14 (2023) 1, pp. 67-93

Persistent link: https://www.econbiz.de/10014234422

The generic drug trilemma

Hemel, Daniel J.; Ouellette, Lisa Larrimore - In: Entrepreneurship and innovation policy and the economy … 2 (2023), pp. 41-77

Persistent link: https://www.econbiz.de/10015049953

Impact of hospital decision-making on drug markets : the case of biosimilars

Kanazawa, Kyogo - 2024

Persistent link: https://www.econbiz.de/10015051304

Pharmaceutical pricing in emerging markets : effects of income, competition, and procurement

Danzon, Patricia Munch; Mulcahy, Andrew W.; Towse, Adrian K. - In: Health economics 24 (2015) 2, pp. 238-252

Persistent link: https://www.econbiz.de/10011317852

Manning, Richard L. - In: International journal of the economics of business 25 (2018) 1, pp. 157-166

Persistent link: https://www.econbiz.de/10011881466